🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to assess the long-term safety of nemo...
Status
Active Not Recruiting
Location
Galderma Investigational Site
Start Date
2021-01-11
Trial ID
NCT04204616
Treatments Being Tested
Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-S...
Status
Active Not Recruiting
Location
Galderma Investigational Site 8749
Start Date
2019-12-30
Trial ID
NCT03989206
Treatments Being Tested
The main purpose of the study is to investigate the efficacy on cutaneous t...
Status
Recruiting
Location
Galderma Investigational Site # 8743
Start Date
2026-02-20
Trial ID
NCT07047690
Treatments Being Tested
The main aim of this study is to assess real-world effectiveness of nemoliz...
Status
Recruiting
Location
Galderma Investigational Site # 8893
Start Date
2025-08-11
Trial ID
NCT06988618
This study was to compare the rate and extent of absorption of a single dos...
Status
Completed
Location
Galderma Investigational Site 7024
Start Date
2022-08-11
Trial ID
NCT05405985
Treatments Being Tested
The aim of this study is to assess the safety and efficacy of nemolizumab i...
Status
Completed
Location
LKH-Univ. Klinikum Graz
Start Date
2017-10-02
Trial ID
NCT03181503
Treatments Being Tested
The primary objective of this study is to investigate the efficacy of nemol...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01
Trial ID
NCT05056779
Treatments Being Tested
This study is being done to test a microdevice, which is a small device des...
Status
Not Yet Recruiting
Location
University of California, San Francisco
Start Date
2026-08-01
Trial ID
NCT07352566
Treatments Being Tested
The primary objective was to assess the efficacy of nemolizumab (CD14152) c...
Status
Completed
Location
Galderma Investigational Site
Start Date
2020-09-11
Trial ID
NCT04501666
Treatments Being Tested
To evaluate the efficacy of nemolizumab in systemic sclerosis patients. To ...
Status
Completed
Location
The University of Tokyo Hospital
Start Date
2022-04-20
Trial ID
NCT05214794
Treatments Being Tested